<html>
<head>PUBMED IDs for CYP2A13</head>
<body bgcolor='#C5F0F2'><h1>CYP2A13</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10353262/'>Expression of CYP2A genes in human liver and extrahepatic tissues.</a> June 3  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10471064/'>Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.</a> September 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10493259/'>The CYP2A subfamily: function, expression and genetic polymorphism.</a> September 24  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11016631/'>Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.</a> October 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11684323/'>Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.</a> October 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12130698/'>Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant.</a> July 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12736711/'>Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array.</a> May 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12814965/'>Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells.</a> June 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12920161/'>Single nucleotide polymorphisms of the human cyp2a13 gene: evidence for a null allele.</a> August 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14505803/'>Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa.</a> September 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14633739/'>Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.</a> November 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15063809/'>Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility.</a> April 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15115698/'>Arg257Cys polymorphism of CYP2A13 in a Chinese population.</a> April 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15175424/'>Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung.</a> June 4  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16054184/'>CYP2S1: a short review.</a> August 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316926/'>CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316921/'>COL1A2 (type I collagen) polymorphisms in the Colorado Indians of Ecuador.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316917/'>Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316914/'>Indian ethnic populations characterized by dopamine (D4) receptor VNTR polymorphism.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316913/'>The spectrum of haemoglobin variants in two scheduled tribes of Sundargarh district in north-western Orissa, India.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16316892/'>-137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.</a> December 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16917071/'>The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.</a> August 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17148654/'>Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation.</a> December 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17717079/'>Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.</a> August 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18669584/'>Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.</a> August 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19018727/'>CYP2A6 polymorphisms and risk for tobacco-related cancers.</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19303722/'>Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.</a> August 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19414505/'>CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.</a> August 12  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19608696/'>The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.</a> January 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19812523/'>CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19996203/'>Smoking-Related Gene Expression in Laser Capture-Microdissected Human Lung.</a> December 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20187624/'>3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.</a> June 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20431511/'>Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphisms.</a> September 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20534012/'>Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians.</a> February 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20673498/'>[Interference of homologous sequences on the SNP study of CYP2A13 gene].</a> August 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20798279/'>The effects of single nucleotide polymorphisms in CYP2A13 on metabolism of 5-methoxypsoralen.</a> March 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20846153/'>Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer.</a> December 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21376776/'>Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues.</a> August 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21438663/'>Interactions among genetic variants in tobacco metabolizing genes and smoking are associated with head and neck cancer susceptibility in North Indians.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21473878/'>Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.</a> July 8  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21606606/'>Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21791872/'>Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22046326/'>'Smoking genes': a genetic association study.</a> March 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22315333/'>An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.</a> August 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22397853/'>Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model.</a> March 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22706231/'>CYP2A6: genetics, structure, regulation, and function.</a> October 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23073733/'>Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.</a> June 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23073722/'>Elucidation of regulatory mechanisms revealed by human promoter sequence analysis of genes co-expressed in forskolin-treated theca cells in PCOS.</a> August 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23142425/'>4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.</a> February 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23720675/'>Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance.</a> May 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23752126/'>Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.</a> February 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23752102/'>Adrenocortical carcinoma is a lynch syndrome-associated cancer.</a> November 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23884085/'>Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model.</a> June 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23884042/'>Impaired default network functional connectivity in autosomal dominant Alzheimer disease.</a> October 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24907355/'>Generation and characterization of a novel CYP2A13--transgenic mouse model.</a> February 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25547627/'>Identification and functional characterization of novel feline cytochrome P450 2A.</a> March 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25667220/'>Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.</a> August 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26084420/'>miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.</a> January 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27725446/'>CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.</a> January 28  2016<br></body></html>
